精神心理指南

订阅

MedSci主页 / 所有栏目 / 精神心理指南

2021 PPA共识声明：精神分裂症阴性症状的非药物治疗

2021-08-31 波兰精神病学协会 Psychiatr Pol

精神分裂症非药物治疗精神分裂症阴性症状

2021年8月，波兰精神病学协会(PPA)发布了精神分裂症阴性症状的非药物治疗共识声明。

中文标题：

2021 PPA共识声明：精神分裂症阴性症状的非药物治疗

英文标题：

Polish Psychiatric Association consensus statement on non-pharmacological methods in the treatment of negative symptoms of schizophrenia

发布机构：

波兰精神病学协会

发布日期：

2021-08-31

简要介绍：

2021年8月，波兰精神病学协会(PPA)发布了精神分裂症阴性症状的非药物治疗共识声明。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 PPA共识声明：精神分裂症阴性症状的非药物治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=47c161c002320088, title=2021 PPA共识声明：精神分裂症阴性症状的非药物治疗, enTitle=Polish Psychiatric Association consensus statement on non-pharmacological methods in the treatment of negative symptoms of schizophrenia, guiderFrom=Psychiatr Pol, authorId=0, author=, summary=2021年8月，波兰精神病学协会(PPA)发布了精神分裂症阴性症状的非药物治疗共识声明。, cover=https://img.medsci.cn/2022113/1642088695616_1608702.png, journalId=0, articlesId=null, associationId=2291, associationName=波兰精神病学协会, associationIntro=波兰精神病学协会(PPA,Polish Psychiatric Association), copyright=0, guiderPublishedTime=Tue Aug 31 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年8月，波兰精神病学协会(PPA)发布了精神分裂症阴性症状的非药物治疗共识声明。</span></p>, tagList=[TagDto(tagId=1344, tagName=精神分裂症), TagDto(tagId=7158, tagName=非药物治疗), TagDto(tagId=28604, tagName=精神分裂症阴性症状)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3853, appHits=128, showAppHits=0, pcHits=397, showPcHits=3725, likes=1, shares=15, comments=4, approvalStatus=1, publishedTime=Thu Jan 13 23:39:23 CST 2022, publishedTimeString=2021-08-31, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Thu Jan 13 23:46:28 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Thu Jan 04 15:08:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 PPA共识声明：精神分裂症阴性症状的非药物治疗.pdf)])
2021 PPA共识声明：精神分裂症阴性症状的非药物治疗.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2152438, encodeId=7dc6215243855, content=精神分裂症, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ec78353474, createdName=ms3000000908088823, createdTime=Sat Aug 12 16:32:33 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1221994, encodeId=9536122199441, content=<a href='/topic/show?id=c9bfe649471' target=_blank style='color:#2F92EE;'>#精神分裂症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76494, encryptionId=c9bfe649471, topicName=精神分裂症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:13:59 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221993, encodeId=21ef1221993e2, content=<a href='/topic/show?id=8f0f9966969' target=_blank style='color:#2F92EE;'>#非药物治疗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99669, encryptionId=8f0f9966969, topicName=非药物治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:13:46 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184115, encodeId=0162118411580, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Jan 14 07:28:06 CST 2022, time=2022-01-14, status=1, ipAttribution=)]
    2023-08-12 ms3000000908088823 来自四川省

    精神分裂症

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2152438, encodeId=7dc6215243855, content=精神分裂症, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ec78353474, createdName=ms3000000908088823, createdTime=Sat Aug 12 16:32:33 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1221994, encodeId=9536122199441, content=<a href='/topic/show?id=c9bfe649471' target=_blank style='color:#2F92EE;'>#精神分裂症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76494, encryptionId=c9bfe649471, topicName=精神分裂症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:13:59 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221993, encodeId=21ef1221993e2, content=<a href='/topic/show?id=8f0f9966969' target=_blank style='color:#2F92EE;'>#非药物治疗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99669, encryptionId=8f0f9966969, topicName=非药物治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:13:46 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184115, encodeId=0162118411580, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Jan 14 07:28:06 CST 2022, time=2022-01-14, status=1, ipAttribution=)]
    2022-05-24 清风徐来2022

    #精神分裂症#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2152438, encodeId=7dc6215243855, content=精神分裂症, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ec78353474, createdName=ms3000000908088823, createdTime=Sat Aug 12 16:32:33 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1221994, encodeId=9536122199441, content=<a href='/topic/show?id=c9bfe649471' target=_blank style='color:#2F92EE;'>#精神分裂症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76494, encryptionId=c9bfe649471, topicName=精神分裂症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:13:59 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221993, encodeId=21ef1221993e2, content=<a href='/topic/show?id=8f0f9966969' target=_blank style='color:#2F92EE;'>#非药物治疗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99669, encryptionId=8f0f9966969, topicName=非药物治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:13:46 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184115, encodeId=0162118411580, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Jan 14 07:28:06 CST 2022, time=2022-01-14, status=1, ipAttribution=)]
    2022-05-24 清风徐来2022

    #非药物治疗#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2152438, encodeId=7dc6215243855, content=精神分裂症, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ec78353474, createdName=ms3000000908088823, createdTime=Sat Aug 12 16:32:33 CST 2023, time=2023-08-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=1221994, encodeId=9536122199441, content=<a href='/topic/show?id=c9bfe649471' target=_blank style='color:#2F92EE;'>#精神分裂症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76494, encryptionId=c9bfe649471, topicName=精神分裂症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:13:59 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1221993, encodeId=21ef1221993e2, content=<a href='/topic/show?id=8f0f9966969' target=_blank style='color:#2F92EE;'>#非药物治疗#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99669, encryptionId=8f0f9966969, topicName=非药物治疗)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=清风徐来2022, createdTime=Tue May 24 11:13:46 CST 2022, time=2022-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184115, encodeId=0162118411580, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Jan 14 07:28:06 CST 2022, time=2022-01-14, status=1, ipAttribution=)]
    2022-01-14 微探

    学习学习

    0

相关指南

2021 精神分裂症中抗精神病药物的循证治疗：S3 指南和当前参考文献

欧洲精神病学协会(EPA,European Psychiatric Association) · 2021-07-17

齐拉西酮治疗精神分裂症临床应用指导建议

中国精神科相关专家小组 · 2021-09-30

2021 JSCNP指南：精神分裂症的药物治疗

日本临床神经精神药理学学会(JSCNP,Japanese Society of Clinical Neuropsychopharmacology) · 2021-08-12

2021 日本专家共识：精神分裂症的药物治疗

暂未更新 · 2021-01-12

2020 APA实践指南：精神分裂症的治疗（第3版）

美国精神病学会(APA,American Psychiatric Association) · 2020-09-01

精神分裂症患者代谢综合征管理的中国专家共识

中华医学会精神病学分会 · 2020-01-30